Back to Journals » Therapeutics and Clinical Risk Management » Volume 3 » Issue 2

Long-term management of gastroesophageal reflux disease with pantoprazole

Authors Theo Scholten

Published 15 May 2007 Volume 2007:3(2) Pages 231—243

Theo Scholten

Allgemeines Krankenhaus Hagen, University of Witten/Herdecke, Germany

Abstract: Gastroesophageal reflux disease (GERD) is a chronic, relapsing disease that can progress to major complications. Affected patients have poorer health-related quality of life than the general population. As GERD requires continued therapy to prevent relapse and complications, most patients with erosive esophagitis require long-term acid suppressive treatment. Thus GERD results in a significant cost burden and poor health-related quality of life. The effective treatment of GERD provides symptom resolution and high rates of remission in erosive esophagitis, lowers the incidence of GERD complications, improves health-related quality of life, and reduces the cost of this disease. Proton pump inhibitors are accepted as the most effective initial and maintenance treatment for GERD. Oral pantoprazole is a safe, well tolerated and effective initial and maintenance treatment for patients with nonerosive GERD or erosive esophagitis. Oral pantoprazole has greater efficacy than histamine H2-receptor antagonists and generally similar efficacy to other proton pump inhibitors for the initial and maintenance treatment of GERD. In addition, oral pantoprazole has been shown to improve the quality of life of patients with GERD and is associated with high levels of patient satisfaction with therapy. GERD appears to be more common and more severe in the elderly, and pantoprazole has shown to be an effective treatment for this at-risk population.

Keywords: pantoprazole, proton pump inhibitor, erosive esophagitis, gastroesophageal reflux disease, tolerability, efficacy

Download Article [PDF] 

Readers of this article also read:

Insulin resistance and inflammation markers in myocardial infarction

Gruzdeva O, Uchasova E, Dyleva Y, Belik E, Shurygina E, Barbarash O

Journal of Inflammation Research 2013, 6:83-90

Published Date: 17 June 2013

Influence of optic disc size on the diagnostic performance of macular ganglion cell complex and peripapillary retinal nerve fiber layer analyses in glaucoma

Cordeiro DV, Lima VC, Castro DP, Castro LC, Pacheco MA, Lee JM, Dimantas MI, Prata TS

Clinical Ophthalmology 2011, 5:1333-1337

Published Date: 19 September 2011

Intranasal ciclesonide for allergic rhinitis

Ben Williams, William B Smith, Frank E Kette

Journal of Asthma and Allergy 2008, 1:49-54

Published Date: 30 November 2008

Resveratrol in prevention and treatment of common clinical conditions of aging

M Andrea Markus, Brian J Morris

Clinical Interventions in Aging 2008, 3:331-339

Published Date: 6 June 2008

A review of nasal polyposis

Jonathan Ray Newton, Kim Wong Ah-See

Therapeutics and Clinical Risk Management 2008, 4:507-512

Published Date: 11 April 2008

Bisoprolol in the treatment of chronic heart failure: from pathophysiology to clinical pharmacology and trial results

Marco Metra, Savina Nodari, Tania Bordonali, Patrizia Milani, Carlo Lombardi, et al

Therapeutics and Clinical Risk Management 2007, 3:569-578

Published Date: 15 September 2007